Hindustan Foods Ltd Q4 FY2025 Concall Summary

Key Takeaways

• PAT crosses INR100 crores milestone despite consumer headwinds, helped by record Q4 revenues and the footwear division finally turning operationally profitable.
• Footwear turnaround is real but fragile: The division posted its highest-ever quarterly revenue and turned PBT-positive ex-ESOP, yet the INR1,000 crores revenue target is "impossible" for FY26 because ramping up means hiring and training 5,000 more people.
• Consumer demand is still weak: Management sees no light at the end of the tunnel for most categories, with April and May no different from the prior quarter; shoes may be the exception.
• The dedicated manufacturing moat held: Not a single customer lost in nearly two decades, and all three ice cream factories carry guaranteed volume offtake agreements, insulating the core from the slowdown.
• What to watch next quarter: Whether footwear's operational momentum sustains into seasonally weaker quarters, any concrete tariff-driven export orders materialize, and whether the consumer demand narrative shifts from "not out of the woods."

Footwear: The Turnaround Story

• First profitable quarter: The footwear division delivered its highest-ever quarterly turnover and turned PBT-positive after stripping out ESOP provisioning, ending a 15-month ramp-up slog since acquiring five northern facilities.
• The INR11 crores loss explained: The full-year footwear loss includes integration costs from unfamiliar northern operations (new vendors, new customers, new norms) plus the accounting impact of the ESOP scheme, not an underlying demand problem.
• South expansion is the near-term lever: A second line at the IGK Chennai facility will double southern capacity in 4–6 months, and southern facilities should hit 30% of northern production by end-Q1 or Q2 FY26.
• Asset-turn inefficiency acknowledged: Management concedes current asset turnover in shoes is inefficient; the record Q4 is the benchmark for how it should perform going forward.
• The INR1,000 crores target is distant: Management calls it "impossible" for FY26 and won't commit to FY27 or FY28, because doubling output means hiring and training nearly 5,000 additional people in an extremely labor-intensive operation.

Sameer Kothari: "While we all are working extremely hard, the shoe business is an extremely manually intensive business, ramping up to double of where we are right now, would involve doubling up of the manpower, which would involve hiring and training nearly 5,000 additional people. As you can imagine, not an easy thing to do."

Consumer Demand: Still in the Woods

• Broad-based softness persists: Management echoes customer CEOs in saying consumption headwinds continue, with April and May showing no improvement over the prior quarter; untimely rains hurt seasonal products.
• Shoes may be the exception: While most categories remain sluggish, management sees footwear as possibly having turned a corner, driven by operational fixes rather than a demand recovery.
• Private-label caution: Management is bearish on domestic private label due to the consumption slowdown hitting legacy brands, D2C brands, and private labels alike, though bullish on export private-label opportunities.
• Take-or-pay flexibility exists: While contracts are honored in letter and spirit, management acknowledges both parties understand ground realities and support each other in difficult times, effectively confirming flexibility without stating it outright.

Sameer Kothari: "So overall, I would say that it's — still we are not out of the woods. I mean my team here hates that phrase out of the woods, but I'm going to continue using it saying that I don't think we are still out of the woods. Maybe in case of shoes, we are, but in case of the rest of the stuff, I think we are still not finding the light at the end of the tunnel."

Dedicated Manufacturing: The Moat

• Zero customer churn in two decades: Management states they have not lost a single dedicated manufacturing customer, with contracts tested by macroeconomic headwinds, consumer behavior shifts, and brand failures.
• Ice cream is fully de-risked: All three factories (Lucknow, Nashik, and the upcoming North India plant) carry guaranteed volume offtake agreements covering 100% of capacity, making seasonality a commercial rather than a utilization problem.
• New Nashik plant online: Commercial production commenced in May 2025, with capitalization expected at INR150–200 crores in FY26.
• North India greenfield plant: A new site has been identified, with operations expected by Q1 FY27 and investment around INR200 crores.
• Contract renewals are sticky: Management says the majority of dedicated contracts get renewed, though they won't claim 100% on a public call.

Sameer Kothari: "I'm reasonably proud to say that we've not lost a customer."

Shared Manufacturing & Margin Dynamics

• The margin framework: In dedicated manufacturing, investors should track absolute EBITDA; in shared manufacturing, EBITDA as a percentage of sales is the right metric, and management is confident they can improve it.
• Employee cost will keep rising: Two new factories coming online plus footwear expansion mean employee costs won't stagnate; management hopes margin improvements on products will compensate.
• Shoe business margin benchmark: Per an analyst's math, a 9% EBITDA margin is achievable in the footwear business, and management confirms this understanding is "quite fair."
• Capital allocation split steady: Nearly 80% of capitalized gross block is dedicated manufacturing, with shared manufacturing at the balance; management expects similar percentages in the medium term.
• Gross block doubling on track: The company continues working toward INR1,800 crores in gross block by end-FY26.

Exports, Tariffs & New Bets

• Tariff opportunity is early-stage: Management is watching the China tariff situation with interest, particularly for the Dr Scholl's facility, but calls it "early days" and reserves comment until there is more clarity given the policy flip-flops.
• China Plus One traction: Cautious optimism about increased sourcing interest from India across footwear, foot care, personal care, and OTC pharma, though the tariff situation remains uncertain.
• OTC Pharma scaling up: Early traction is promising; the Baddi facility will hit full capacity utilization on the back of two new clients, with peak revenue expected by FY27.
• Kabadiwala acquisition: A proposed investment of up to INR5 crores for a substantial minority stake, described as strategic and symbiotic, aimed at turbocharging EPR compliance for FMCG clients while uplifting the informal waste ecosystem.

Sameer Kothari: "As you would have seen, there's been too much of flip-flop on that tariff already. So let us reserve our comments and maybe in the next investor call, if we have some more clarity about the tariffs, I'll be able to come back to you on what's happening on that front."

Capital Allocation & Disclosures

• New segment disclosure: The company will now split dedicated vs. shared manufacturing in its reporting, giving investors a clearer view of the stability-versus-operating-leverage mix.
• ESOP scheme rolled out: Aimed at rewarding high performers, enhancing retention, and attracting the next generation of leaders across Hindustan Foods.
• Preferential allotment in footwear subsidiary: Completed, giving employees a tangible stake; a liquidity event for KNS Shoetech shareholders is contemplated at some undefined future point.
• Baddi new customer: Production slated to begin by Q3 FY26, with all regulatory approvals secured.
• Karnataka shoe expansion delayed: Not expected to commercialize for at least nine months, with investment around INR50 crores.

Vimal Solanki: "Sustainability isn't just a check box on our to-do list. It's central to how we view the future of manufacturing."

Guidance & Commitments

Key Metrics